Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
14 May 2019
Initial Success for a New Treatment for Autoimmune Diseases
With approximately 10% of Europeans living with an autoimmune disease,1 an effective and safe treatment is imperative. Now, in a human clinical trial…
14 May 2019
New proteins identified could revolutionise muscle stem cell therapeutics
“We believe we have found promising drug targets that direct muscle stem cells to ‘make the right decision’ and stimulate muscle repair…
11 Feb 2019
Response to Rituximab Cannot be Predicted by Smoking Status
RHEUMATOID ARTHRITIS (RA) is influenced by many factors, including alcohol consumption, smoking, and obesity. However, until recently no study had…
11 Feb 2019
Improving Cardiovascular Outcomes for Rheumatoid Arthritis Patients
ATHEROSCLEROSIS rates were reduced in patients with rheumatoid arthritis as a result of adopting a treat-to-target approach compared with a traditional…
9
Mins
13 Dec 2018
Central Processes Underlying Fibromyalgia
Fibromyalgia is a common chronic pain disorder characterised by a robust clinical phenotype with principal features that include widespread pain and…
9
Mins
13 Dec 2018
Drilling Down to the Bone: Evaluating Bone Marrow Lesions in Osteoarthritis
Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and affects the whole joint. Changes in cartilage integrity, subchondral bone, and…
3 Dec 2018
Probiotics Can Successfully Enhance Bone Growth
Deteriorations in bone health can begin as early as 40 years of age, resulting in bone loss and a diagnosis of osteoporosis, which leads to a high rate…
3 Dec 2018
Location of Unique Skeletal Stem Cell Identified
Stem cells in the bones are believed to have the potential to heal various bone injuries. Unfortunately, little is known about where skeletal stem cells…
Loading posts...
« Previous
1
…
60
61
62
63
64
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View